These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 4427990)

  • 1. The effects of scopolamine and physostigmine on fixed-interval behaviour in the rat.
    McKim WA
    Psychopharmacologia; 1974; 39(3):237-44. PubMed ID: 4427990
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of physostigmine, atropine and scopolamine on behavior maintained by a multiple schedule of food presentation in the mouse.
    Wenger GR
    J Pharmacol Exp Ther; 1979 Apr; 209(1):137-43. PubMed ID: 430373
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of azaprophen, scopolamine and trihexyphenidyl on schedule-controlled behavior, before and after chronic physostigmine.
    Genovese RF
    Eur J Pharmacol; 1990 Feb; 176(3):271-9. PubMed ID: 2328755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of the behavioral effects of aprophen, atropine and scopolamine to antagonism of the behavioral effects of physostigmine.
    Genovese RF; Elsmore TF; Witkin JM
    Pharmacol Biochem Behav; 1990 Sep; 37(1):117-22. PubMed ID: 2263653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions between scopolamine and muscarinic cholinergic agonists or cholinesterase inhibitors on spatial alternation performance in rats.
    Shannon HE; Bemis KG; Hendrix JC; Ward JS
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1071-7. PubMed ID: 2262893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of selective central muscarinic blockade on schedule-controlled behavior and on the rate-decreasing effects of physostigmine.
    Hymowitz N; Brezenoff HE
    Pharmacol Biochem Behav; 1984 Jul; 21(1):109-15. PubMed ID: 6463084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholinergic blockade and response timing in rats.
    Soffié M; Lejeune H
    Psychopharmacology (Berl); 1992; 106(2):215-20. PubMed ID: 1549649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of scopolamine and physostigmine with ECS and one trial learning.
    Davis JW; Thomas RK; Adams HE
    Physiol Behav; 1971 Mar; 6(3):219-22. PubMed ID: 5125477
    [No Abstract]   [Full Text] [Related]  

  • 9. Physostigmine-insensitive behavioral excitatory effects of atropine in squirrel monkeys.
    Witkin JM; Markowitz RA; Barrett JE
    Pharmacol Biochem Behav; 1989 Jan; 32(1):309-15. PubMed ID: 2734342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ontogenetic aspects of central cholinergic involvement in spontaneous alternation behavior.
    Egger GJ; Livesey PJ; Dawson RG
    Dev Psychobiol; 1973 Jul; 6(4):289-99. PubMed ID: 4793359
    [No Abstract]   [Full Text] [Related]  

  • 11. Tolerance to oxotremorine's effects on schedule-controlled behavior in physostigmine-tolerant rats.
    Genovese RF; Elsmore TF; King LR
    Life Sci; 1988; 43(7):571-6. PubMed ID: 3398709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impairment of one-trial passive avoidance learning in mice by scopolamine, scopolamine methylbromide, and physostigmine.
    Bohdanecký Z; Jarvik ME
    Int J Neuropharmacol; 1967 May; 6(3):217-22. PubMed ID: 6037526
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of tetrahydroaminoacridine and physostigmine on scopolamine-induced free swim behavior in the rat.
    Dokla CP; Rydelek-Fitzgerald L
    Psychopharmacology (Berl); 1991; 103(2):240-3. PubMed ID: 2027924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The behavioral effects of heptyl physostigmine, a new cholinesterase inhibitor, in tests of long-term and working memory in rodents.
    Dawson GR; Bentley G; Draper F; Rycroft W; Iversen SD; Pagella PG
    Pharmacol Biochem Behav; 1991 Aug; 39(4):865-71. PubMed ID: 1763105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discriminative stimulus properties of physostigmine in rats.
    Tang AH; Franklin SR
    Eur J Pharmacol; 1988 Aug; 153(1):97-104. PubMed ID: 3215280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholinergic drug effects on antidepressant-induced behaviour in the forced swimming test.
    Mancinelli A; Borsini F; d'Aranno V; Lecci A; Meli A
    Eur J Pharmacol; 1988 Dec; 158(3):199-205. PubMed ID: 3253098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of physostigmine on relative acetylcholine output induced by systemic treatment with scopolamine in in vivo microdialysis of rat frontal cortex.
    Liu JK; Kato T
    Neurochem Int; 1994 Jun; 24(6):589-96. PubMed ID: 7981642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of scopolamine and physostigmine on acquisition of morphine-treated rats in Morris water maze performance.
    Zheng XG; Li XW; Yang XY; Sui N
    Acta Pharmacol Sin; 2002 May; 23(5):477-80. PubMed ID: 11978201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of physostigmine, scopolamine, and mecamylamine on the sleeping time induced by ketamine in the rat.
    Figallo EM; Wingard LB
    Psychopharmacology (Berl); 1979 Mar; 61(1):59-62. PubMed ID: 108720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of scopolamine on three different types of suppressed behavior of rats.
    McKim WA
    Pharmacol Biochem Behav; 1980 Mar; 12(3):409-12. PubMed ID: 7393939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.